ACM
DRTS icon

Atalaya Capital Management’s Alpha Tau Medical DRTS Stock Holding History

Atalaya Capital Management’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$68.8K Sell
27,180
-46,562
-63% -$118K 0.15% 22
2024
Q1 		$218K Hold
73,742
– – 0.26% 23
2023
Q4 		$222K Hold
73,742
– – 0.32% 22
2023
Q3 		$279K Hold
73,742
– – 0.31% 28
2023
Q2 		$322K Buy
+73,742
New +$264K 0.16% 44

Other funds holding DRTS

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Atalaya Capital Management's DRTS Position: Q2 2024 in Review

Atalaya Capital Management reduced its Alpha Tau Medical (DRTS) stake by 63% in Q2 2024, selling an estimated $118K and leaving 27,180 shares worth $68.8K. The position accounts for 0.15% of the portfolio, ranked #22.

Atalaya Capital Management first reported a position in DRTS in Q2 2023 and has held it in 5 quarters since. The position peaked at $322K in Q2 2023. 24 funds tracked by Wall St. Rank hold DRTS as of Q2 2024.

  • Atalaya Capital Management held 27,180 shares of Alpha Tau Medical worth $68.8K as of Q2 2024.
  • Atalaya Capital Management sold 46,562 Alpha Tau Medical shares in Q2 2024, an estimated $118K.
  • Alpha Tau Medical made up 0.15% of Atalaya Capital Management's portfolio in Q2 2024, its #22 holding.
  • Atalaya Capital Management first reported a position in Alpha Tau Medical in Q2 2023 and has held it in 5 quarters since.
  • Atalaya Capital Management's Alpha Tau Medical position peaked at $322K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2024.

Based on Atalaya Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.